Lupus Nephritis IgG Induction of Calcium/Calmodulin‐Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function

Kidney podocytes and their slit diaphragms prevent urinary protein loss. T cells from patients with systemic lupus erythematosus display increased expression of calcium/calmodulin‐dependent protein kinase IV (CaMKIV). The present study was undertaken to investigate the role of CaMKIV in podocyte function in lupus nephritis (LN).

[1]  G. Tsokos,et al.  KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3+ regulatory T cells in MRL/lpr mice , 2014, Autoimmunity.

[2]  T. Rauen,et al.  CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance. , 2014, The Journal of clinical investigation.

[3]  J. Reiser,et al.  Abatacept in B7-1-positive proteinuric kidney disease. , 2014, The New England journal of medicine.

[4]  J. Reiser,et al.  Proteinuria: Abate or applaud abatacept in proteinuric kidney disease? , 2014, Nature Reviews Nephrology.

[5]  Yong Cui,et al.  Genetic susceptibility to SLE: recent progress from GWAS. , 2013, Journal of autoimmunity.

[6]  G. Tsokos,et al.  Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus , 2012, The Journal of Immunology.

[7]  P. Mundel,et al.  Cell biology and pathology of podocytes. , 2012, Annual review of physiology.

[8]  K. Kyriacou,et al.  Podocyte main slit diaphragm proteins, nephrin and podocin, are affected at early stages of lupus nephritis and correlate with disease histology , 2011, Lupus.

[9]  G. Tsokos,et al.  Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. , 2011, Arthritis and rheumatism.

[10]  Dennis B. Troup,et al.  NCBI GEO: archive for functional genomics data sets—10 years on , 2010, Nucleic Acids Res..

[11]  M. Zeier,et al.  Nocturnal versus conventional haemodialysis : some current issues , 2022 .

[12]  Emil R. Unanue,et al.  Podocytes use FcRn to clear IgG from the glomerular basement membrane , 2008, Proceedings of the National Academy of Sciences.

[13]  Anna Maria Masci,et al.  Calmodulin-dependent kinase IV links Toll-like receptor 4 signaling with survival pathway of activated dendritic cells. , 2008, Blood.

[14]  一瀬 邦弘.  Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model , 2007 .

[15]  M. Saleem,et al.  Direct effects of dexamethasone on human podocytes. , 2006, Kidney international.

[16]  H. Sugiyama,et al.  2-(8-Hydroxy-6-Methoxy-1-Oxo-1H-2-Benzopyran-3-yl) Propionic Acid, an Inhibitor of Angiogenesis, Ameliorates Renal Alterations in Obese Type 2 Diabetic Mice , 2006, Diabetes.

[17]  K. Eguchi,et al.  Antiangiogenic endostatin peptide ameliorates renal alterations in the early stage of a type 1 diabetic nephropathy model. , 2005, Diabetes.

[18]  G. Remuzzi,et al.  In response to protein load podocytes reorganize cytoskeleton and modulate endothelin-1 gene: implication for permselective dysfunction of chronic nephropathies. , 2005, The American journal of pathology.

[19]  C. Mawrin,et al.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.

[20]  E. Lewis,et al.  Glomerular podocytopathy in patients with systemic lupus erythematosus. , 2004, Journal of the American Society of Nephrology : JASN.

[21]  R. Kalluri,et al.  Induction of B7-1 in podocytes is associated with nephrotic syndrome. , 2004, The Journal of clinical investigation.

[22]  F. Gejyo,et al.  Differentiation-Induced Cultured Podocytes Express Endocytically Active Megalin, a Heymann Nephritis Antigen , 2004, Nephron Experimental Nephrology.

[23]  Lee Hebert,et al.  The classification of glomerulonephritis in systemic lupus erythematosus revisited. , 2004, Kidney international.

[24]  K. Lai,et al.  The pathogenetic role of immunoglobulin G from patients with systemic lupus erythematosus in the development of lupus pleuritis. , 2003, Rheumatology.

[25]  J. Kopp,et al.  Update in podocyte biology: putting one's best foot forward , 2003, Current opinion in nephrology and hypertension.

[26]  T. Chan,et al.  Mesangial cell-binding anti-DNA antibodies in patients with systemic lupus erythematosus. , 2002, Journal of the American Society of Nephrology : JASN.

[27]  M. O'hare,et al.  A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. , 2002, Journal of the American Society of Nephrology : JASN.

[28]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[29]  J. Haymann,et al.  Characterization and localization of the neonatal Fc receptor in adult human kidney. , 2000, Journal of the American Society of Nephrology : JASN.

[30]  R. Zeller,et al.  Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. , 1997, Experimental cell research.

[31]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[32]  Q. Ma,et al.  Inhibition of calcium(2+)/calmodulin-dependent protein kinase type IV ameliorates experimental nephrotic syndrome. , 2013, Internal medicine.

[33]  T. Rauen,et al.  Calcium/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis , 2011 .

[34]  L. Pasquier,et al.  Orphanet Journal of Rare Diseases BioMed Central Review , 2006 .